Ponatinib
Ponatinib is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively. Ponatinib (AP24534) inhibits autophagy.
Trivial name | AP24534 |
Catalog Number | S1490 |
Molecular Formula | C29H27F3N6O |
CAS# | 943319-70-8 |
Inchi | InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) |
Inchi Key | PHXJVRSECIGDHY-UHFFFAOYSA-N |
SMILES | CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5 |
Size | 10mg |
Supplier Page | http://www.selleckchem.com/products/AP24534.html |
Additional Information | https://file.selleck.cn/downloads/struct/Ponatinib-AP24534-chemical-structure-S1490.gif |